Compare Abeona Therapeutics Inc (ABEO) vs DraftKings Inc (DKNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs DraftKings Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while DraftKings Inc trades at $25.23 (market cap $12.58B). The key difference: DraftKings Inc is far larger — about 29.9× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, DraftKings Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | DKNG | |
|---|---|---|
Market Cap | $421.19M | $12.58B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $48.23 |
52-Week Low | $4.17 | $20.72 |
Enterprise Value | $276.10M | $13.51B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About DraftKings Inc
DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.
Read more on DKNG →
